Skip to content
Vaccine Formulation Institute Logo
  • Activities
    • Supporting vaccine community with adjuvant and formulation expertise

      Academia

      Supporting vaccine community with adjuvant and formulation expertise

      Supporting adjuvanted vaccine development up to industrial scale

      Industry

      Supporting adjuvanted vaccine development up to industrial scale

      Helping donors and funders carry out vaccine development programs

      Funders

      Helping donors and funders carry out vaccine development programs

      • Activities
      • SWE adjuvant
  • About Us
    • Open-acess adjuvants and vaccine formulations for Global Health

      • Not-for-profit
      • History
      • Careers
  • News
  • Publications
  • Contact
  • Activities
    • Supporting vaccine community with adjuvant and formulation expertise

      Academia

      Supporting vaccine community with adjuvant and formulation expertise

      Supporting adjuvanted vaccine development up to industrial scale

      Industry

      Supporting adjuvanted vaccine development up to industrial scale

      Helping donors and funders carry out vaccine development programs

      Funders

      Helping donors and funders carry out vaccine development programs

      • Activities
      • SWE adjuvant
  • About Us
    • Open-acess adjuvants and vaccine formulations for Global Health

      • Not-for-profit
      • History
      • Careers
  • News
  • Publications
  • Contact

Publications

COVID-19

  • All (49)
  • COVID-19 (1)
  • LMQ adjuvant (8)
  • LQ adjuvant (10)
  • SQ adjuvant (4)
  • SWE adjuvant (19)

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern

  • All
  • /COVID-19
  • /SWE adjuvant

Garg R, Liu Q, Van Kessel J, et al. Vaccine. Published online May 14, 2024. doi:10.1016/j.vaccine.2024.05.028

VFI headquarters and Geneva laboratories

Rue du Champ-Blanchod 4
1228 Plan-les-Ouates
Switzerland

VFI Lausanne laboratories

Route de la Corniche 5
1066 Epalinges
Switzerland

contact@vformulation.org
VFI on LinkedIn
  • Home
  • Contact
  • Imprint
  • Privacy Policy

© 2025 Vaccine Formulation Institute